Search Results - "Adekanye, Glory"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics

    409 Development of ex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics by Edelstein, Jasmine N, Hill, Tyler F, Leiken, Michael D, Molloy, Katherine M, Adekanye, Glory, Bullock, Caroline, Lazorchak, Adam S, Aryee, Ken-Edwin, Rawlings, David J, James, Richard G, Morgan, Richard A, Arlauckas, Sean P

    Published in Journal for immunotherapy of cancer (02-11-2023)
    “…BackgroundBispecific T Cell Engagers (BiTEs), consisting of an anti-CD3 scFv fused to an anti-tumor antigen scFv, are highly effective in the treatment of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    409 Development ofex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics

    409 Development ofex vivo precision gene engineered B cell medicines that produce highly active and sustained levels of transgenic anti-tumor biologics by Edelstein, Jasmine N, Hill, Tyler F, Leiken, Michael D, Molloy, Katherine M, Adekanye, Glory, Bullock, Caroline, Lazorchak, Adam S, Ken-Edwin Aryee, Rawlings, David J, James, Richard G, Morgan, Richard A, Arlauckas, Sean P

    Published in Journal for immunotherapy of cancer (01-11-2023)
    “…BackgroundBispecific T Cell Engagers (BiTEs), consisting of an anti-CD3 scFv fused to an anti-tumor antigen scFv, are highly effective in the treatment of…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: